to chronic rejection and transplant failure&periodleadto chronic rejection and transplant failure&period

a transplanted organ to failcan causea transplanted organ to fail

along with cell , organ , or tissue transplantation and graft - versus - host disease , autoimmune diseases such as chronic rheumatism , multiple sclerosis , typecausedalong with cell , organ , or tissue transplantation and graft - versus - host disease , autoimmune diseases such as chronic rheumatism , multiple sclerosis , type

from the immune response of the body against transplanted organ or tissues from a different person whose tissue antigens are not compatible with those of the recipientresultingfrom the immune response of the body against transplanted organ or tissues from a different person whose tissue antigens are not compatible with those of the recipient

from selective elimination of T regs in the same model [ 25resultingfrom selective elimination of T regs in the same model [ 25

from the direct response of T cells to MHC molecules , which function as histocompatibility antigensresultfrom the direct response of T cells to MHC molecules , which function as histocompatibility antigens

from the immune response of the body against transplanted organ or tissues from a different person whose tissue antigens are Calcium channel blocker maintenance therapyresultingfrom the immune response of the body against transplanted organ or tissues from a different person whose tissue antigens are Calcium channel blocker maintenance therapy

graft failure in pediatric keratoplasty vary between 11 % [ 2 ] and 50 % [ 3 ] in literatureresultinggraft failure in pediatric keratoplasty vary between 11 % [ 2 ] and 50 % [ 3 ] in literature

from patients own bodyis originatedfrom patients own body

to the death of the patientsmight leadto the death of the patients

liver failure(passive) caused byliver failure

cardiac failure(passive) caused bycardiac failure

the fatality of the patients , about 10 % of the patients passed on annuallymight triggerthe fatality of the patients , about 10 % of the patients passed on annually

in failure at 6 monthsresultingin failure at 6 months

in the death of 5 % -12 % of patients grafted for aplastic anemiahas resultedin the death of 5 % -12 % of patients grafted for aplastic anemia

to the failure of the organ and the death of the recipientcan leadto the failure of the organ and the death of the recipient

transplanted cornea opacity to failcould causetransplanted cornea opacity to fail

depression , grief , and a sense of loss for donors [ 12can causedepression , grief , and a sense of loss for donors [ 12

in redness , sensitivity to light and blurred visionmay resultin redness , sensitivity to light and blurred vision

to a greater transplant - related mortality , particularly in patients with SAA.3leadsto a greater transplant - related mortality , particularly in patients with SAA.3

up to 10 % of early transplant failures and also leads to a higher incidence of chronic rejection [ 3causesup to 10 % of early transplant failures and also leads to a higher incidence of chronic rejection [ 3

when OX40 blockade was given combined with CD28 / CD40 blockade , while grafts were rejected when OX40 blockade was given alone [ 65was preventedwhen OX40 blockade was given combined with CD28 / CD40 blockade , while grafts were rejected when OX40 blockade was given alone [ 65

his inclusion on the recipient listto preventhis inclusion on the recipient list

or reduced by reducing the levels of exposed HLA antigens on the surface of transplant cellscan be preventedor reduced by reducing the levels of exposed HLA antigens on the surface of transplant cells

from increased immune activationresultingfrom increased immune activation

the body from mounting an immune response against the transplanted organpreventsthe body from mounting an immune response against the transplanted organ

DC activation in vitro ( for example , sirolimus [ 112 ] and tacrolimus [ 113preventedDC activation in vitro ( for example , sirolimus [ 112 ] and tacrolimus [ 113

via adequate lymphodepletion [ 73,74may be preventedvia adequate lymphodepletion [ 73,74

severe injurycan causesevere injury

probablyresultsprobably

the ignitionmay preventthe ignition

from a T lymphocyte - initiated proliferative responseto resultfrom a T lymphocyte - initiated proliferative response

in mice and chickens if foreign cells from the future graft donor are introduced into the recipient during foetal or neo - natal life ( i.e. when the animals are immunologically immaturecan be ... preventedin mice and chickens if foreign cells from the future graft donor are introduced into the recipient during foetal or neo - natal life ( i.e. when the animals are immunologically immature

by transferring cells from an unrelated donor during neonatal life ... 54 , 55could be preventedby transferring cells from an unrelated donor during neonatal life ... 54 , 55

to graft losscould leadto graft loss

to loss - of - function of the administered cellsmay leadto loss - of - function of the administered cells

when donor lymphocytes attack the graft recipientresultwhen donor lymphocytes attack the graft recipient

to immune dysfunctionwould leadto immune dysfunction

to ris- ing costs in the Medicare ESRD programhas also contributedto ris- ing costs in the Medicare ESRD program

from undesired immune responsesresultsfrom undesired immune responses